The Contraceptive Technology Innovation (CTI) Exchange is a platform for increasing global access to resources on contraceptive research, development, registration, and introduction through collaboration and knowledge sharing. The site features Calliope, the Contraceptive Pipeline Database, which provides information on new and future contraceptive products, including long-acting and novel products currently only available in limited markets.

The Track20 Project, implemented by Avenir Health, monitors progress towards achieving the goals of the global FP2020 initiative, adding an additional 120 million modern method users between 2012 and 2020 in the world’s 69 poorest countries. Track20 works directly with governments in participating FP2020 countries to collect, analyze and use data to monitor progress annually in family planning and to actively use data to improve family planning strategies and plans. Track20 activities and efforts are focused on countries that chose to make a commitment to the FP2020 global initiative, referred to as Track20 Focus Countries. The remaining FP2020 countries, referred to as Additional Track20 Countries, will also receive some technical support.

The G-FINDER project tracks annual investment in research and development for new products and technologies that are designed to address the persistent global health challenges that disproportionately affect the world’s most disadvantaged people. The project’s goal is to provide funders, policy makers, researchers, advocates, journalists and others with an accurate understanding of the research and development funding landscape for neglected diseases and other global health priorities. The G-FINDER data portal provides open access to all of the underlying data captured by the G-FINDER survey every year since 2007.

PMA generates frequent, high-quality surveys monitoring key health indicators in nine countries in Africa and Asia. Data is available open-source for research, program planning, and policy-making. PMA family planning briefs provide a snapshot of select indicators through charts, graphs and tables. Key indicators for family planning include unmet need for family planning, modern contraceptive prevalence rate (​mCPR), and family planning access, equity, quality, and choice.

The Reproductive Health Supplies Visualizer (RH Viz) is a series of public-facing dashboards designed to help the RH community see integrated and aggregated supply chain inventory, order, and shipment data.

The Global Family Planning Visibility and Analytics Network (VAN) captures data from multiple sources to improve supply chain visibility. The VAN offers a platform to assess supply needs, prioritize them, and act when supply imbalances loom.

The ExpandNet bibliography includes publications, websites, grey literature, and conference reports that either directly address scaling up or provide valuable insights on scaling up. Included are materials from a range of global health and development technical areas as well as the various sciences relevant to scale up.

This is an open-access collection of health market literature, featuring documents and related resources needed to understand, develop, and intervene in different global health markets.

This list was curated by the Knowledge SUCCESS team by asking projects funded by USAID Population and Reproductive Health to submit resources that they have developed or used.

The purpose of the toolkit is to bring together existing learning and guidance as a starting point for stakeholders to begin SRH preparedness work. Within the SRH sector the field of preparedness is relatively new and growing. More collective effort is required to further evaluate the impact of preparedness efforts and push the field forward. This effort is a first attempt at synthesizing draft guidance for SRH preparedness, and is intended for field testing. The toolkit recognizes the longstanding work of the field of emergency and disaster risk management, and endeavors to bridge that work with the human rights-oriented and peoplecentered field of sexual and reproductive health.